Basic Stats
| CIK | 1734750 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Movano Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Con |
|
| August 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 28, 2025 |
Movano Health Granted Listing Extension by Nasdaq Exhibit 99.1 Movano Health Granted Listing Extension by Nasdaq PLEASANTON, CA August 28, 2025 - Movano Health (Nasdaq: MOVE)(the “Company”) announced today that, by letter received on August 27, 2025, the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) has determined to grant the Company’s request to continue its listing on Nasdaq, subject to (i) the Company regaining |
|
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 22, 2025 |
Exhibit 99.1 Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q PLEASANTON, CA August 22, 2025 - Movano Health (Nasdaq: MOVE)(the “Company”) announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that because the Company had not yet fil |
|
| August 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Conf |
|
| August 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 13, 2025 MOVANO INC. |
|
| August 15, 2025 |
SEC File Number 001-40254 CUSIP Number 62459M 206 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2025 MOVANO INC. |
|
| July 11, 2025 |
Exhibit 99.1 Movano Health Plans to Timely Request a Hearing before a Nasdaq Hearings Panel Received Delisting Notice from Nasdaq Related to Minimum Bid Price Requirement and Late Filing of the Form 10-Q for the period ended March 31, 2025 PLEASANTON, CA July 11, 2025 - Movano Health (Nasdaq: MOVE) (the “Company”) announced today that, on July 7, 2025, it received a delisting determination from Th |
|
| July 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 7, 2025 MOVANO INC. |
|
| June 25, 2025 |
Exhibit 16.1 June 25, 2025 U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by the Movano Inc. included under Item 4.01 of its Current Report on Form 8-K dated June 24, 2025 to be filed with the Securities and Exchange Commission. We agree with the statements concerning our Firm contained therein. Sincerely, /s/ Mo |
|
| June 25, 2025 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 24, 2025 MOVANO INC. |
|
| May 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 23, 2025 |
Exhibit 99.1 Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q PLEASANTON, CA May 23, 2025 - Movano Health (Nasdaq: MOVE)(the “Company”) announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that because the Company had not yet filed |
|
| May 21, 2025 |
SEC File Number 001-40254 CUSIP Number 62459M107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 19, 2025 |
Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 15, 2025 MOVANO INC. |
|
| April 9, 2025 |
Exhibit 10.20 SECOND AMENDMENT TO LEASE THIS SECOND AMENDMENT TO LEASE (“Amendment”) is made and entered into as of the 9th day of January, 2024, but is retroactively effective as of December 1, 2023, by and between BERNAL CORPORATE PARK 11-E, LLC, a Delaware limited liability company (“Landlord”), and MOVANO INC., a Delaware corporation (“Tenant”). R E C I T A L S : A. Landlord and Tenant entered |
|
| April 9, 2025 |
Exhibit 10.21 THIRD AMENDMENT TO LEASE THIS THIRD AMENDMENT TO LEASE ("Amendment") is made and entered into as of the 19th day of June, 2024 by and between BERNAL CORPORATE PARK II-E, LLC, a Delaware limited liability company ("Landlord"), and MOVANO INC., a Delaware corporation ("Tenant"). R E C I T A L S : A. Landlord and Tenant entered into that certain Office Lease dated as of March 29, 2021 ( |
|
| April 9, 2025 |
Exhibit 10.19 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT TO LEASE (“Amendment”) is made and entered into as of the 22nd day of April, 2022, by and between BERNAL CORPORATE PARK II-E, LLC, a Delaware limited liability company (“Landlord”), and MOYANO INC., a Delaware corporation (“Tenant”). R E C I T A L S : A. Landlord and Tenant entered into that certain Office Lease dated as of March 29, 2021 |
|
| April 9, 2025 |
Exhibit 19.1 Movano Inc. Insider Trading Policy Movano Inc. (the “Company”) has adopted this Insider Trading Policy (the “Policy”) to promote compliance with federal securities laws by directors, officers, employees and consultants of the Company and its affiliates, as well as any immediate family members sharing the household of any of the foregoing, and any entities controlled by any of the fore |
|
| April 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| April 9, 2025 |
Office Lease, dated March 29, 2021, by and between Bernal Corporate Park II-E, LLC and the Company Exhibit 10.18 OFFICE LEASE BERNAL CORPORATE PARK BERNAL CORPORATE PLAZA II BERNAL CORPORATE PARK II-E, LLC, a Delaware limited liability company, as Landlord, and MOVANO INC., a Delaware corporation, as Tenant. BERNAL CORPORATE PARK BERNAL CORPORATE PLAZA II SUMMARY OF BASIC LEASE INFORMATION The parties hereto agree to the following terms of this Summary of Basic Lease Information (the “Summary”) |
|
| April 9, 2025 |
MOVANO INC. Up to $8,886,273 Common Stock Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-264116 AMENDMENT NO. 3 DATED APRIL 9, 2025 To Prospectus Supplements dated August 15, 2022, May 29, 2024 and September 16, 2024 (To Prospectus dated May 25, 2022) MOVANO INC. Up to $8,886,273 Common Stock This Amendment No. 3 to Prospectus Supplements (the “Amendment”) amends and supplements the information in our prospectus, dated Ma |
|
| April 9, 2025 |
Exhibit 21.1 SUBSIDIARIES OF MOVANO INC. Registrant’s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of December 31, 2024 Movano Irel |
|
| March 31, 2025 |
SEC File Number 001-40254 CUSIP Number 62459M107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 2, 2025 Movano Inc. |
|
| November 14, 2024 |
Exhibit 99 Movano Health Reports Q3 2024 Financial Results and Provides Business Update Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. |
|
| November 14, 2024 |
Form of Warrant issued in August 2024 Exhibit 4.11 WARRANT NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFF |
|
| November 14, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2024 Movano Inc. |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant a |
|
| October 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2024 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| October 25, 2024 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. MOVANO INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Third Amended and Restated Certificate of Incorporation of the Corporation is hereby amended by adding the following para |
|
| October 25, 2024 |
Exhibit 99.1 Movano Health Announces Reverse Stock Split Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024 PLEASANTON, CA October 25, 2024 - Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the “Reverse Stock Split”), effective at 12:01 a.m. Eastern time on October 29, 2024. The C |
|
| September 16, 2024 |
MOVANO INC. Up to $8,259,292 Common Stock Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-264116 AMENDMENT NO. 2 DATED SEPTEMBER 16, 2024 To Prospectus Supplements dated August 15, 2022 and May 29, 2024 (To Prospectus dated May 25, 2022) MOVANO INC. Up to $8,259,292 Common Stock This Amendment No. 2 to Prospectus Supplements (the “Amendment”) amends and supplements the information in our prospectus, dated May 25, 2022 (the |
|
| August 16, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Movano Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equit |
|
| August 16, 2024 |
As filed with the Securities and Exchange Commission on August 15, 2024 As filed with the Securities and Exchange Commission on August 15, 2024 Registration No. |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as spe |
|
| August 14, 2024 |
Exhibit 99 Movano Health Reports Q2 2024 Financial Results and Provides Business Update Prepares for September 17, 2024, Evie Ring back in stock date Announces brand partnership with digital creator Heidi D’Amelio Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. |
|
| August 14, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 14, 2024 Movano Inc. |
|
| July 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2024 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| July 10, 2024 |
Amendment No. 2 to Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan Exhibit 10.1 Amendment No. 2 of the Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan This Amendment No. 2 (“Amendment”), dated May 15, 2024, of the Amended and Restated 2019 Omnibus Incentive Plan (the “Existing Plan”; as amended by Amendment No. 1, dated April 15, 2022, and as amended hereby, the “Plan”), of Movano Inc., a Delaware corporation (the “Company”), is made and adopted by t |
|
| July 10, 2024 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. MOVANO INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Third Amended and Restated Certificate of Incorporation of the Corporation is hereby amended by deleting the first paragr |
|
| May 29, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 29, 2024 MOVANO INC. |
|
| May 29, 2024 |
MOVANO INC. Up to $3,406,141 Common Stock Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-264116 AMENDMENT NO. 1 DATED MAY 29, 2024 To Prospectus Supplement dated August 15, 2022 (To Prospectus dated May 25, 2022) MOVANO INC. Up to $3,406,141 Common Stock This Amendment No. 1 to Prospectus Supplement, or this Amendment, amends our prospectus supplement dated August 15, 2022, or the Prospectus Supplement. This Amendment sho |
|
| May 29, 2024 |
Amendment No. 1 to At the Market Issuance Agreement, dated May 29, 2024 Exhibit 10.1 AMENDMENT NO. 1 TO AT THE MARKET ISSUANCE AGREEMENT May 29, 2024 B. Riley Securities, Inc. 299 Park Avenue, 21st Floor New York, New York 10171 JonesTrading Institutional Services LLC 325 Hudson St., 6th Floor New York, NY 10013 Ladies and Gentlemen: Movano Inc., a Delaware corporation (the “Company”) and B. Riley Securities, Inc. (“B. Riley”) are parties to that certain At the Market |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Co |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Con |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as sp |
|
| May 15, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2024 Movano Inc. |
|
| May 15, 2024 |
SEC File Number 001-40254 CUSIP Number 62459M107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 15, 2024 |
Exhibit 99.1 Movano Health Reports Q1 2024 Financial Results and Provides Business Update Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. – May 15, 2024 – Movano Health (Nasdaq: MOVE), a pione |
|
| May 8, 2024 |
Filed Pursuant to Rule 424(b)(7) Registration No. 333-278885 PROSPECTUS MOVANO INC. 36,594,656 Shares of Common Stock 39,015,499 Shares of Common Stock Underlying Warrants 2,420,843 Shares of Common Stock Underlying Pre-Funded Warrants This prospectus relates to up to 78,030,998 shares of common stock, par value $0.0001 per share, that the selling stockholders identified in this prospectus may sel |
|
| May 3, 2024 |
Movano Inc. 6800 Koll Center Parkway, Pleasanton, CA 94566 Movano Inc. 6800 Koll Center Parkway, Pleasanton, CA 94566 May 3, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: J. Conlon Danberg Re: Movano Inc. Registration Statement on Form S-3 File No. 333-278885 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), registrant Movano Inc. (the |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 |
|
| April 23, 2024 |
Filing Fee Table (filed herewith) Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Movano Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee New |
|
| April 23, 2024 |
As filed with the Securities and Exchange Commission on April 23, 2024 As filed with the Securities and Exchange Commission on April 23, 2024 Registration No. |
|
| April 16, 2024 |
Incentive-Based Compensation Recovery Policy Exhibit 97.1 Movano Inc. Incentive-BASED Compensation Recovery Policy 1. Policy Purpose. The purpose of this Movano Inc. (the “Company”) Incentive-Based Compensation Recovery Policy (this “Policy”) is to enable the Company to recover Erroneously Awarded Compensation in the event that the Company is required to prepare an Accounting Restatement. This Policy is intended to comply with the requiremen |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| April 16, 2024 |
Exhibit 21.1 SUBSIDIARIES OF MOVANO INC. Registrant’s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of December 31, 2023 Movano Irel |
|
| April 10, 2024 |
MOVE / Movano Inc. / APPEL PETER A - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| April 9, 2024 |
MOVE / Movano Inc. / Tamkin Gregory S - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| April 9, 2024 |
EX-99.1 2 ea020358501ex99-1movano.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of a statement on Schedule 13G and any and all amendments thereto as well as any other form(s), statement |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 4, 2024 Movano Inc. |
|
| April 4, 2024 |
Exhibit 99.1 Movano Health Reports 2023 Financial Results and Provides Business Update Executes $24 million funding extending cash runway Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities Plans launch of Evie Med Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. – April 4, 2024 – Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported fou |
|
| April 3, 2024 |
Form of Securities Purchase Agreement, dated April 2, 2024 Exhibit 10.1 MOVANO INC. SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of April 2, 2024, between Movano Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers attached hereto as Addendum A (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the |
|
| April 3, 2024 |
Form of Registration Rights Agreement Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of , 2024, between Movano, Inc., a Delaware corporation (the “Company”), and the persons listed on the Schedule of Buyers attached to the Purchase Agreement (as defined below) (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pu |
|
| April 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 2, 2024 MOVANO INC. |
|
| April 3, 2024 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| April 3, 2024 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| April 1, 2024 |
SEC File Number 001-40254 CUSIP Number 62459M107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 29, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 29, 2023 MOVANO INC. |
|
| November 29, 2023 |
Exhibit 99.1 Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement Pleasanton, Calif. – Nov. 29, 2023 – Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announces the successful ecommerce launch of the Evie Ring, the innovative smart ring designed for women, which has exceeded the Company’s |
|
| November 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2023 MOVANO INC. |
|
| November 16, 2023 |
4,235,304 Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 PROSPECTUS SUPPLEMENT (to the Prospectus dated May 25, 2022) 4,235,304 Shares of Common Stock We are offering 4,235,304 shares of our common stock pursuant to this prospectus supplement and accompanying prospectus. The public offering price for each share of common stock is $0.85. See “Description of Securities We Are Offering” in this p |
|
| November 15, 2023 |
Movano Health Prices $3.6 Million Public Offering Exhibit 99.2 Movano Health Prices $3.6 Million Public Offering PLEASANTON, Calif., November 15, 2023 – Movano Health (Nasdaq: MOVE) (“Movano Health” or the “Company”), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it has priced a $3.6 million underwritten public offering of 4,235,304 shares of its |
|
| November 15, 2023 |
Exhibit 1.1 4,235,304 Shares MOVANO INC. COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT November 14, 2023 November 14, 2023 The Benchmark Company, LLC As the Representative of the several underwriters 150 East 58th St., 17th Floor New York, NY 10155 Ladies and Gentlemen: Movano Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters nam |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 15, 2023 Movano Inc. |
|
| November 15, 2023 |
Movano Health Announces Proposed Public Offering Exhibit 99.1 Movano Health Announces Proposed Public Offering PLEASANTON, Calif., November 14, 2023 – Movano Health (Nasdaq: MOVE) (“Movano Health” or the “Company”), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock in an underwritten public offering |
|
| November 15, 2023 |
Exhibit 99.1 Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results Conference call begins at 8:30 a.m. Pacific time today Pleasanton, Calif. – November 15, 2023 – Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, reported financial results for the thre |
|
| November 15, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2023 MOVANO INC. |
|
| November 14, 2023 |
SUBJECT TO COMPLETION, DATED NOVEMBER 14, 2023 Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but the information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell nor do they s |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant a |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as spe |
|
| August 14, 2023 |
Exhibit 99 Movano Health Provides Business Update and Reports Second Quarter 2023 Financial Results Conference call begins at 2:00 p. |
|
| August 14, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 14, 2023 Movano Inc. |
|
| June 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2023 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 21, 2023 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. MOVANO INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Third Amended and Restated Certificate of Incorporation of the Corporation is hereby amended by deleting the first paragr |
|
| June 14, 2023 |
8,000,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 PRELIMINARY PROSPECTUS SUPPLEMENT (to the Prospectus dated May 25, 2022) 8,000,000 Shares of Common Stock We are offering 8,000,000 shares of our common stock pursuant to this prospectus supplement and accompanying prospectus. The public offering price for each share of common stock is $1.00. See “Description of Securities We Are Offerin |
|
| June 13, 2023 |
Underwriting Agreement dated as of June 13, 2023 between the Company and The Benchmark Company, LLC* Exhibit 1.1 8,000,000 Shares MOVANO INC. COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT June 13, 2023 June 13, 2023 The Benchmark Company, LLC As the Representative of the several underwriters 150 East 58th St., 17th Floor New York, NY 10155 Ladies and Gentlemen: Movano Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Sc |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 13, 2023 MOVANO INC. |
|
| June 13, 2023 |
Movano Health Prices $8.0 Million Public Offering Exhibit 99.2 Movano Health Prices $8.0 Million Public Offering Pleasanton, Calif., June 13, 2023 –Movano Health (Nasdaq: MOVE) (“Movano Health” or the “Company”), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it has priced an $8.0 million underwritten public offering of 8,000,000 shares of its com |
|
| June 13, 2023 |
Movano Health Announces Proposed Public Offering Exhibit 99.1 Movano Health Announces Proposed Public Offering Pleasanton, Calif., June 12, 2023 –Movano Health (Nasdaq: MOVE) (“Movano Health” or the “Company”), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock in an underwritten public offering. All |
|
| June 12, 2023 |
SUBJECT TO COMPLETION, DATED JUNE 12, 2023 Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but the information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell nor do they s |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2023 Movano Inc. |
|
| May 15, 2023 |
Exhibit 99 Movano Health Provides Business Update and Reports First Quarter 2023 Financial Results Conference call begins at 9:00 a. |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as sp |
|
| April 28, 2023 |
DEF 14A 1 ny20008282x2def14a.htm DEF14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate bo |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| April 17, 2023 |
PRE 14A 1 ny20008282x1pre14a.htm PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate b |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| March 30, 2023 |
Exhibit 21.1 SUBSIDIARIES OF MOVANO INC. Registrant’s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of December 31, 2022 Movano Irel |
|
| March 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 20, 2023 Movano Inc. |
|
| March 20, 2023 |
Exhibit 99 Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results Conference call begins at 9:00 a. |
|
| January 31, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 27, 2023 MOVANO INC. |
|
| January 31, 2023 |
Exhibit 4.2 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of January 31, 2023 (the “Issuance Date”) between Movano Inc., a company incorporated under the laws of the State of Delaware (the “Company”), and Pacific Stock Transfer Company, a Nevada Corporation (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement (“Underwrit |
|
| January 31, 2023 |
Movano Health Prices $6.5 Million Public Offering Exhibit 99.2 Movano Health Prices $6.5 Million Public Offering Pleasanton, Calif., Jan. 27, 2023 –Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it has priced a $6.5 million underwritten public offering of 4,644,000 shares of its common stock and warrants to purchase u |
|
| January 31, 2023 |
Form of Warrant to Purchase Common Stock Exhibit 4.1 COMMON STOCK PURCHASE WARRANT MOVANO INC. Warrant Shares: Initial Issue Date: January 31, 2023 Initial Exercise Date: January 31, 2023 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after |
|
| January 31, 2023 |
4,644,000 Shares of Common Stock Warrants to Purchase up to 2,322,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 PROSPECTUS SUPPLEMENT (to the Prospectus dated May 25, 2022) 4,644,000 Shares of Common Stock Warrants to Purchase up to 2,322,000 Shares of Common Stock We are offering 4,644,000 shares of our common stock and warrants to purchase up to 2,322,000 shares of our common stock pursuant to this prospectus supplement and accompanying prospect |
|
| January 31, 2023 |
Exhibit 1.1 UNDERWRITING AGREEMENT between MOVANO INC. and NEWBRIDGE SECURITIES CORPORATION Common Stock January 27, 2023 Newbridge Securities Corporation 1200 North Federal Highway, Suite 400 Boca Raton, Florida 33432 Ladies and Gentlemen: The undersigned, Movano Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) wi |
|
| January 31, 2023 |
Movano Health Announces Proposed Public Offering Exhibit 99.1 Movano Health Announces Proposed Public Offering Pleasanton, Calif., Jan. 26, 2023 –Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock and warrants to purchase common stock in an underwritten public offering. |
|
| January 26, 2023 |
SUBJECT TO COMPLETION, DATED JANUARY 26, 2023 Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, but the information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell nor do they seek an offer |
|
| November 14, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2022 Movano Inc. |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant a |
|
| November 14, 2022 |
Exhibit 99.1 Movano Health Provides Business Update and Reports Third Quarter 2022 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? November 14, 2022 ? Today, Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, reported financial results for the three months endi |
|
| August 15, 2022 |
Exhibit 107 Calculation of Filing Fee Tables ??Form S-8??.. (Form Type) ?????.????? Movano Inc. ??????????.. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate A |
|
| August 15, 2022 |
As filed with the Securities and Exchange Commission on August 15, 2022 As filed with the Securities and Exchange Commission on August 15, 2022 Registration No. |
|
| August 15, 2022 |
Movano Inc. 2021 Inducement Award Plan * Exhibit 4.6 MOVANO INC. 2021 INDUCEMENT AWARD PLAN Movano Inc., a Delaware corporation sets forth herein the terms of its 2021 Inducement Award Plan. 1. PURPOSE The purpose of the Plan is to provide, among other equity awards, non-qualified stock options to individuals not previously employees of the Company (or following such individuals? bona fide period of non-employment with the Company), as a |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as spe |
|
| August 15, 2022 |
Form Stock Option Award Agreement under Movano Inc. 2021 Inducement Award Plan * Exhibit 4.7 NOTICE OF GRANT OF STOCK OPTION MOVANO, INC. 2021 INDUCEMENT AWARD PLAN FOR GOOD AND VALUABLE CONSIDERATION, Movano, Inc. (the ?Company?) hereby grants, pursuant to the provisions of the Movano, Inc. 2021 Inducement Award Plan (the ?Plan?), to the Grantee designated below (?Grantee?) a Stock Option to purchase the number of Shares specified below (the ?Option?). The Option shall be sub |
|
| August 15, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 15, 2022 Movano Inc. |
|
| August 15, 2022 |
Exhibit 99 Movano Inc. Provides Business Update and Reports Second Quarter 2022 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? August 15, 2022 ? Today, Movano Inc. (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, reported financial results for the three months ending June 30, 2022 and pr |
|
| August 15, 2022 |
EX-1.1 2 f10q0622ex1-1movano.htm AT THE MARKET ISSUANCE AGREEMENT, DATED AUGUST 15, 2022 BY AND BETWEEN THE COMPANY, AS ISSUER, AND B. RILEY SECURITIES, INC. AS SALE AGENT Exhibit 1.1 Execution Version MOVANO INC. Common Stock, Par Value $0.0001 Per Share At the Market Issuance Agreement August 15, 2022 B. Riley Securities, Inc. 299 Park Avenue, 21st Floor New York, NY 10171 Ladies and Gentlemen: |
|
| August 15, 2022 |
MOVANO INC. Common Stock Having an Aggregate Offering Price of up to $50,000,000 424B5 1 ea164347-424b5movanoinc.htm PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 PROSPECTUS SUPPLEMENT (to the Prospectus dated May 25, 2022) MOVANO INC. Common Stock Having an Aggregate Offering Price of up to $50,000,000 We have entered into an At the Market Issuance Agreement (the “Issuance Agreement”) with B. Riley Securities, Inc. (the “Sales Agent”) rela |
|
| June 22, 2022 |
Exhibit 10.1 Amendment No. 1 of the Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan This Amendment No. 1 (?Amendment?), dated April 15, 2022, of the Amended and Restated 2019 Omnibus Incentive Plan (the ?Existing Plan?; as amended hereby, the ?Plan?), of Movano Inc., a Delaware corporation (the ?Company?), is made and adopted by the Company, subject to approval of the stockholders of |
|
| June 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2022 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 26-0579295 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 24, 2022 |
Movano Inc. 6800 Koll Center Parkway, Pleasanton, CA 94566 Movano Inc. 6800 Koll Center Parkway, Pleasanton, CA 94566 May 24, 2022 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Crawford Re: Movano Inc. Registration Statement on Form S-3 File No. 333-264116 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the ?Securities Act?), registrant Movano Inc. (the ? |
|
| May 19, 2022 |
As filed with the Securities and Exchange Commission on May 19, 2022 As filed with the Securities and Exchange Commission on May 19, 2022 Registration No. |
|
| May 12, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 12, 2022 Movano Inc. |
|
| May 12, 2022 |
Exhibit 99.1 Movano Inc. Provides Business Update and Reports First Quarter 2022 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? May 12, 2022 ? Today, Movano Inc. (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, reported financial results for the three months ending March 31, 2022 and pro |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as sp |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ?) Filed by the Registrant ? Filed by a Party other than the Registrant ?? Check the appropriate box: ?? Preliminary Proxy Statement ?? Con |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ?) Filed by the Registrant ? Filed by a Party other than the Registrant ?? Check the appropriate box: ?? Preliminary Proxy Statement ?? Con |
|
| April 18, 2022 |
Exhibit 99.1 Movano Welcomes Nan Kirsten Forte, a Pioneer and Innovator in Digital Health, as Its Newest Board Member Veteran health media executive joins the board of directors as Movano prepares for growth and commercialization Pleasanton, Calif., April 18, 2022 - Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announ |
|
| April 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 15, 2022 Movano Inc. |
|
| April 4, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Movano Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forwa |
|
| April 4, 2022 |
Exhibit 4.8 INDENTURE between Movano Inc. and [] TRUSTEE Dated as of [] Providing for Issuance of Debt Securities in Series Reconciliation and tie between Indenture, dated as of , and the Trust Indenture Act of 1939, as amended. Trust Indenture Act of 1939 Section Indenture Section 310(a)(1) 6.11 (a)(2) 6.11 (a)(3) TIA (a)(4) Not Applicable (a)(5) TIA (b) 6.9; 6.11; TIA 311(a) TIA (b) TIA 312(a) 6 |
|
| April 4, 2022 |
As filed with the Securities and Exchange Commission on April 4, 2022 As filed with the Securities and Exchange Commission on April 4, 2022 Registration No. |
|
| March 30, 2022 |
EXHIBIT 21.1 SUBSIDIARIES OF MOVANO INC. Registrant?s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of December 31, 2021 Movano Irel |
|
| March 30, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 24, 2022 Movano Inc. |
|
| March 30, 2022 |
EXHIBIT 4.6 DESCRIPTION OF COMMON STOCK OF MOVANO INC. REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a brief description of our common stock. This summary does not purport to be complete in all respects. This description is subject to and qualified entirely by the terms of our Third Amended and Restated Certificate of Incorporation (the ?Certificate of I |
|
| March 30, 2022 |
Non-Employee Director Compensation Policy † EXHIBIT 10.3 Movano Inc. Director Compensation Policy Members of the Board of Directors (the ?Board?) of Movano Inc. (the ?Company?) who are not employees of the Company or any subsidiary of the Company (?non-employee directors?) shall receive compensation for their services on the Board in accordance with this Director Compensation Policy (this ?Policy?). Cash Compensation Each non-employee direc |
|
| March 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| March 30, 2022 |
Exhibit 99 Movano Inc. Provides Business Update and Reports Fourth Quarter 2021 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? March 24, 2022 ? Today, Movano Inc. (NASDAQ:MOVE) reported financial results for the three months ending December 31, 2021 and provided a business update. With a mission to empower and inspire you to live a healthier, happier |
|
| February 4, 2022 |
MOVE / Movano Inc / Ho William Tai-Wei - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 4, 2022 |
MOVE / Movano Inc / Tamkin Gregory S - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 4, 2022 |
Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of a statement on Schedule 13G and any and all amendments thereto as well as any other form(s), statement(s), report(s), and/or document(s) related thereto with respe |
|
| November 12, 2021 |
Exhibit 99 Movano Inc. Provides Business Update and Reports Third Quarter 2021 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? November 11, 2021 ? Today, Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to help prevent and better manage chronic diseases, reported financi |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant a |
|
| November 12, 2021 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 11, 2021 Movano Inc. |
|
| August 19, 2021 |
As filed with the Securities and Exchange Commission on August 19, 2021 S-8 1 ea146004-s8movanoinc.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on August 19, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 26-0579295 (State or other jurisdiction |
|
| August 12, 2021 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 12, 2021 Movano Inc. |
|
| August 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as spe |
|
| August 12, 2021 |
Exhibit 99 Movano Inc. Provides Business Update and Reports Second Quarter 2021 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? August 12, 2021 ? Today, Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to help prevent and better manage chronic diseases, reported financia |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as sp |
|
| May 13, 2021 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 13, 2021 Movano Inc. |
|
| May 13, 2021 |
Exhibit 99 Movano Inc. Provides Business Update and Reports First Quarter 2021 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? May 13, 2021 ? Today, Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to help prevent and better manage chronic diseases, reported financial re |
|
| March 25, 2021 |
Exhibit 3.1 Third amended and restated CERTIFICATE OF INCORPORATION OF Movano Inc. The present name of the corporation is Movano Inc. The corporation was incorporated under the name ?Maestro Sensors Inc.? by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on January 30, 2018. This Third Amended and Restated Certificate of Incorporation o |
|
| March 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 24, 2021 Movano Inc. |
|
| March 25, 2021 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF MOVANO INC. ARTICLE I Meeting of Stockholders Section 1.1. Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resolution of the board of directors (the ?Board of Directors? |
|
| March 24, 2021 |
MOVANO INC. 8,500,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-252671 Registration No. 333-254602 MOVANO INC. 8,500,000 Shares of Common Stock This is the initial public offering of shares of our common stock. Prior to this offering, there has been no public market for our common stock. The initial public offering price is $5.00 per share. We have applied to list our common stock on the Nasdaq Capital Mark |
|
| March 23, 2021 |
As filed with the Securities and Exchange Commission on March 23, 2021 Registration No. |
|
| March 19, 2021 |
8-A12B 1 ea137915-8a12bmovanoinc.htm FOR REGISTRATION OF CERTAIN CLASSES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 26-0579295 (State or other jurisdiction of incor |
|
| March 18, 2021 |
March 18, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason L. Drory and Tim Buchmiller Re: Movano Inc. Registration Statement on Form S-1 File No. 333-252671 Acceleration Request Requested Date: March 22, 2021 Requested Time: 5:00 p.m., Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the |
|
| March 18, 2021 |
March 18, 2021 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| March 17, 2021 |
Exhibit 4.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPLI |
|
| March 17, 2021 |
As filed with the Securities and Exchange Commission on March 17, 2021 Registration No. |
|
| March 17, 2021 |
Form of Underwriting Agreement Exhibit 1.1 MOVANO INC. UNDERWRITING AGREEMENT New York, New York , 2021 National Securities Corporation, As Representative of the Several Underwriters 200 Vesey Street, 25th Floor New York, NY 10281 Ladies and Gentlemen: The undersigned, Movano Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the ?Company?), a company formed under the laws of Delaware, hereby confir |
|
| March 10, 2021 |
Offer Letter, dated February 8, 2021, by and between the Registrant and John Mastrototaro † Exhibit 10.17 February 8, 2021 John Mastrototaro [email protected] Re: Offer of Employment by Movano Inc. Dear John: I am very pleased to confirm our offer to you of employment with Movano Inc. (the ?Company?). The terms of our offer and the benefits currently provided by the Company are as follows: 1. Position and Start Date. You are being offered the position of Chief Executive Officer, and you |
|
| March 10, 2021 |
Form of Underwriting Agreement Exhibit 1.1 MOVANO INC. UNDERWRITING AGREEMENT New York, New York , 2021 National Securities Corporation, As Representative of the Several Underwriters 200 Vesey Street, 25th Floor New York, NY 10281 Ladies and Gentlemen: The undersigned, Movano Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the ?Company?), a company formed under the laws of Delaware, hereby confir |
|
| March 10, 2021 |
Exhibit 10.3 Movano Inc. Director Compensation Policy Members of the Board of Directors (the ?Board?) of Movano Inc. (the ?Company?) who are not employees of the Company or any subsidiary of the Company (?non-employee directors?) shall receive compensation for their services on the Board in accordance with this Director Compensation Policy (this ?Policy?). Cash Compensation Each non-employee direc |
|
| March 10, 2021 |
Exhibit 10.20 FIRST AMENDMENT TO EMPLOYMENT LETTER AGREEMENT This First Amendment (this ?Amendment?) to that certain Employment Offer Letter Agreement dated November 29, 2019 (the ?Agreement?), by and between Jeremy Cogan (the ?Employee?) and Movano Inc. (the ?Company?), is effective February 10, 2021. WHEREAS, the parties desire to amend the Agreement as set forth herein; NOW, THEREFORE, in consi |
|
| March 10, 2021 |
Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan † Exhibit 10.1 MOVANO INC. AMENDED AND RESTATED 2019 OMNIBUS INCENTIVE PLAN Movano Inc. sets forth herein the terms and conditions of its Amended and Restated 2019 Omnibus Incentive Plan. The Plan was initially adopted by the Board and the stockholders of the Company on March 13, 2018. The Plan, as previously amended and restated, was adopted by the Board effective November 18, 2019, and approved by |
|
| March 10, 2021 |
Exhibit 3.3 Third amended and restated CERTIFICATE OF INCORPORATION OF Movano Inc. The present name of the corporation is Movano Inc. The corporation was incorporated under the name ?Maestro Sensors Inc.? by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on January 30, 2018. This Third Amended and Restated Certificate of Incorporation o |
|
| March 10, 2021 |
Exhibit 10.19 FIRST AMENDMENT TO EMPLOYMENT LETTER AGREEMENT This First Amendment (this ?Amendment?) to that certain Employment Offer Letter Agreement dated November 29, 2019 (the ?Agreement?), by and between Phil Kelly (the ?Employee?) and Movano Inc. (the ?Company?), is effective February 10, 2021. WHEREAS, the parties desire to amend the Agreement as set forth herein; NOW, THEREFORE, in conside |
|
| March 10, 2021 |
Exhibit 4.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPLI |
|
| March 10, 2021 |
Exhibit 4.1 |
|
| March 10, 2021 |
Amended and Restated Bylaws of the Registrant, to be in effect upon completion of this offering Exhibit 3.4 AMENDED AND RESTATED BYLAWS OF MOVANO INC. ARTICLE I Meeting of Stockholders Section 1.1. Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resolution of the board of directors (the ?Board of Directors? |
|
| March 10, 2021 |
As filed with the Securities and Exchange Commission on March 10, 2021 Registration No. |
|
| March 10, 2021 |
Exhibit 10.18 FIRST AMENDMENT TO EMPLOYMENT LETTER AGREEMENT This First Amendment (this ?Amendment?) to that certain Employment Offer Letter Agreement dated November 29, 2019 (the ?Agreement?), by and between Michael Leabman (the ?Employee?) and Movano Inc. (the ?Company?), is effective February 10, 2021. WHEREAS, the parties desire to amend the Agreement as set forth herein; NOW, THEREFORE, in co |
|
| February 25, 2021 |
K&L Gates LLP 300 South Tryon Street, suite 1000 Charlotte, NC 28202 T +1 704 331 7400 F +1 704 331 7598 klgates. |
|
| February 2, 2021 |
Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of [], 2019 (the “Effective Date”), is by and among Movano Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers, attached hereto as Exhibit A (individually, a “Buyer” and collectively, the “Buyers”). RECITALS A. The Company and each Buyer is execut |
|
| February 2, 2021 |
Exhibit 4.4 WARRANT NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFE |
|
| February 2, 2021 |
Form of 2020 Subordinated Convertible Promissory Note* Exhibit 4.5 NEITHER THIS NOTE NOR THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF APPLICABLE STATES. THIS NOTE AND SUCH SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE |
|
| February 2, 2021 |
Offer Letter, dated November 29, 2019, by and between the Registrant and Michael Leabman † Exhibit 10.5 November 29, 2019 Michael Leabman 2307 Grosvenor Heights court Livermore, CA 94550 Re: Offer of Employment by Movano Inc. Dear Michael: This offer letter (this “Amended and Restated Offer Letter”) is to confirm the terms of your offer of employment with Movano Inc., a Delaware corporation (the “Company”), and amends, restates and supersedes in its entirety your prior employment agreem |
|
| February 2, 2021 |
Exhibit 4.6 WARRANT NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFE |
|
| February 2, 2021 |
Exhibit 10.13 AMENDMENT TO THE SERIES A PURCHASE AGREEMENT This Amendment (this “Amendment”), dated as of August 27, 2019, is by and among Movano Inc. (f/k/a Maestro Sensors Inc.), a Delaware corporation (the “Company”), and the other Persons party hereto. Capitalized terms used, but not defined, herein shall have the same respective meanings ascribed to such terms in the Series A Purchase Agreeme |
|
| February 2, 2021 |
Offer Letter, dated November 29, 2019, by and between the Registrant and Phil Kelly †* Exhibit 10.6 November 29, 2019 Phil Kelly 4606 Jared Court Rocklin, CA 95765 Re: Offer of Employment by Movano Inc. Dear Phil: This offer letter (this “Amended and Restated Offer Letter”) is to confirm the terms of your offer of employment with Movano Inc., a Delaware corporation (the “Company”), and amends, restates and supersedes in its entirety your prior employment agreement with the Company d |
|
| February 2, 2021 |
Offer Letter, dated November 29, 2019, by and between the Registrant and J. Cogan † Exhibit 10.7 November 29, 2019 Jeremy Cogan 6035 Estates Dr. Oakland, CA 94611 Re: Offer of Employment by Movano Inc. Dear J.: This offer letter (this “Amended and Restated Offer Letter”) is to confirm the terms of your offer of employment with Movano Inc., a Delaware corporation (the “Company”), and amends, restates and supersedes in its entirety that certain Offer Letter, dated April 11, 2019, b |
|
| February 2, 2021 |
Exhibit 10.17 August 27, 2020 Movano Inc. 6200 Stoneridge Mall Rd., Suite 300 Pleasanton, CA 94588 Attention: Michael Leabman, CEO Re: Agreement Dear Michael: This letter agreement (the “Agreement”) between Movano Inc. (fka Maestro Sensors Inc.) (together with its subsidiaries and successors, the “Company”) and Emily Wang Fairbairn (“Emily”) and Maestro Venture Partners LLC, and each of my other a |
|
| February 2, 2021 |
As filed with the Securities and Exchange Commission on February 2, 2021 Registration No. |
|
| February 2, 2021 |
Exhibit 10.4 INDEMNIFICATION AGREEMENT FOR MOVANO INC. This Indemnification Agreement (this “Agreement”) is effective as of [●], between Movano Inc., a Delaware corporation (the “Company”), and [●] (“Indemnitee”). RECITALS A. Indemnitee’s service to the Company substantially benefits the Company. B. Individuals are reluctant to serve as directors or officers of corporations or in certain other cap |
|
| February 2, 2021 |
Second Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect* Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. A Delaware Corporation (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) Movano Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “DGCL”), DOES HEREBY CERTIFY: 1. That the name of thi |
|
| February 2, 2021 |
Form of 2020 Note Purchase Agreement Exhibit 10.16 NOTE PURCHASE AGREEMENT This Note Purchase Agreement (this “Agreement”) is made as of [], 2020 by and among Movano Inc., a Delaware corporation (the “Company”), and the parties listed on the Schedule of Investors attached to this Agreement as Exhibit A (each individually an “Investor” and collectively the “Investors”). A. The Company currently requires funds to help finance its opera |
|
| February 2, 2021 |
Exhibit 10.15 AMENDMENT TO THE SERIES B PURCHASE AGREEMENT This Amendment (this “Amendment”), dated as of December 2, 2019, is by and among Movano Inc. (f/k/a Maestro Sensors Inc.), a Delaware corporation (the “Company”), and the other Persons party hereto. Capitalized terms used, but not defined, herein shall have the same respective meanings ascribed to such terms in the Series B Purchase Agreem |
|
| February 2, 2021 |
Bylaws of the Registrant, as currently in effect* Exhibit 3.2 BYLAWS OF MOVANO INC. Article I CORPORATE OFFICES 1.1 Registered Office. The registered office of this corporation (the “Company”) is 251 Little Falls Drive, Wilmington, County of New Castle, DE 19808. The name of tis registered agent at such address is Corporation Service Company. 1.2 Other Offices. The Company’s board of directors (the “Board”) may at any time establish other offices |
|
| February 2, 2021 |
Exhibit 10.10 CONSENT AND AMENDMENT AGREEMENT This CONSENT AND AMENDMENT AGREEMENT (this “Agreement”), dated as of [ ], 2019, is by and among Movano Inc. (f/k/a Maestro Sensors Inc.), a Delaware corporation (the “Company”), and the other Persons party hereto. Capitalized terms used, but not defined, herein shall have the same meaning ascribed to such terms in the Series A Purchase Agreement (as de |
|
| February 2, 2021 |
Exhibit 10.14 AMENDMENT TO THE SERIES A PURCHASE AGREEMENT This Amendment (this “Amendment”), dated as of December 2, 2019, is by and among Movano Inc. (f/k/a Maestro Sensors Inc.), a Delaware corporation (the “Company”), and the other Persons party hereto. Capitalized terms used, but not defined, herein shall have the same respective meanings ascribed to such terms in the Series A Purchase Agreem |
|
| February 2, 2021 |
Exhibit 4.3 WARRANT NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFE |
|
| February 2, 2021 |
Exhibit 10.8 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of [], 2018 (the “Effective Date”), is by and among Maestro Sensors Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers, attached hereto as Exhibit A (individually, a “Buyer” and collectively, the “Buyers”). RECITALS A. The Company and each Buyer i |
|
| February 2, 2021 |
Exhibit 10.12 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT FOR INVESTORS THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is effective as of March 28, 2019 by and among Movano Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”. A. The Company and |
|
| February 2, 2021 |
Form of Stock Option Award Agreement under 2019 Omnibus Incentive Plan † Exhibit 10.2 NOTICE OF GRANT OF STOCK OPTION MOVANO, INC. AMENDED AND RESTATED 2019 OMNIBUS INCENTIVE PLAN FOR GOOD AND VALUABLE CONSIDERATION, Movano, Inc. (the “Company”) hereby grants, pursuant to the provisions of the Movano, Inc. Amended and Restated 2019 Omnibus Incentive Plan (the “Plan”), to the Grantee designated below (“Grantee”) a Stock Option to purchase the number of Shares specified |
|
| February 2, 2021 |
Exhibit 10.9 REGISTRATION RIGHTS AGREEMENT FOR INVESTORS THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of [], 2018, by and among Maestro Sensors Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”. A. In connection with the Securities Purchase Agreement by and |
|
| January 11, 2021 |
Confidential Draft No. 2 as submitted confidentially to the Securities and Exchange Commission on January 11, 2021. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STAT |
|
| August 31, 2020 |
As submitted confidentially to the Securities and Exchange Commission on August 31, 2020. |
|
| August 31, 2020 |
K&L Gates LLP 300 South Tryon Street, suite 1000 Charlotte, NC 28202 T +1 704 331 7400 F +1 704 331 7598 klgates. |
|
| August 31, 2020 |
Exhibit 10.16 August 27, 2020 Movano Inc. 6200 Stoneridge Mall Rd., Suite 300 Pleasanton, CA 94588 Attention: Michael Leabman, CEO Re: Agreement Dear Michael: This letter agreement (the “Agreement”) between Movano Inc. (fka Maestro Sensors Inc.) (together with its subsidiaries and successors, the “Company”) and Emily Wang Fairbairn (“Emily”) and Maestro Venture Partners LLC, and each of my other a |
|
| June 30, 2020 |
MOVANO INC. WARRANT TO PURCHASE COMMON STOCK EX-4.3 4 filename4.htm Exhibit 4.3 WARRANT NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND APPLICABLE STATE SECURITIES LAWS AND, ACCOR |
|
| June 30, 2020 |
Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. A Delaware Corporation (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) Movano Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “DGCL”), DOES HEREBY CERTIFY: 1. That the name of thi |
|
| June 30, 2020 |
EX-10.7 9 filename9.htm Exhibit 10.7 November 29, 2019 Jeremy Cogan 6035 Estates Dr. Oakland, CA 94611 Re: Offer of Employment by Movano Inc. Dear J.: This offer letter (this “Amended and Restated Offer Letter”) is to confirm the terms of your offer of employment with Movano Inc., a Delaware corporation (the “Company”), and amends, restates and supersedes in its entirety that certain Offer Letter, |
|
| June 30, 2020 |
Exhibit 10.5 November 29, 2019 Michael Leabman 2307 Grosvenor Heights court Livermore, CA 94550 Re: Offer of Employment by Movano Inc. Dear Michael: This offer letter (this “Amended and Restated Offer Letter”) is to confirm the terms of your offer of employment with Movano Inc., a Delaware corporation (the “Company”), and amends, restates and supersedes in its entirety your prior employment agreem |
|
| June 30, 2020 |
INDEMNIFICATION AGREEMENT MOVANO INC. EX-10.4 6 filename6.htm Exhibit 10.4 INDEMNIFICATION AGREEMENT FOR MOVANO INC. This Indemnification Agreement (this “Agreement”) is effective as of [●], between Movano Inc., a Delaware corporation (the “Company”), and [●] (“Indemnitee”). RECITALS A. Indemnitee’s service to the Company substantially benefits the Company. B. Individuals are reluctant to serve as directors or officers of corporations |
|
| June 30, 2020 |
Exhibit 10.6 November 29, 2019 Phil Kelly 4606 Jared Court Rocklin, CA 95765 Re: Offer of Employment by Movano Inc. Dear Phil: This offer letter (this “Amended and Restated Offer Letter”) is to confirm the terms of your offer of employment with Movano Inc., a Delaware corporation (the “Company”), and amends, restates and supersedes in its entirety your prior employment agreement with the Company d |
|
| June 30, 2020 |
As submitted confidentially to the Securities and Exchange Commission on June 30, 2020. |
|
| June 30, 2020 |
MOVANO INC. WARRANT TO PURCHASE COMMON STOCK Exhibit 4.4 WARRANT NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFE |
|
| June 30, 2020 |
BYLAWS OF MOVANO INC. Article I CORPORATE OFFICES EX-3.2 3 filename3.htm Exhibit 3.2 BYLAWS OF MOVANO INC. Article I CORPORATE OFFICES 1.1 Registered Office. The registered office of this corporation (the “Company”) is 251 Little Falls Drive, Wilmington, County of New Castle, DE 19808. The name of tis registered agent at such address is Corporation Service Company. 1.2 Other Offices. The Company’s board of directors (the “Board”) may at any time |
